Both groups returned to their initial values, with CON reaching this level after 24 h pi and CAR after 48 h pi
According to FDA prescribing information, nausea occurs in 17-25% of patients taking Mounjaro and 24-31% with Zepbound, constipation in 10-17% (Mounjaro) and 16-24% (Zepbound), and diarrhea in 12-17% (Mounjaro) and 18-23% (Zepbound), with incidence varying by dose
Bottom line Tirzepatide (Mounjaro, Zepbound) and semaglutide (Ozempic, Wegovy, Rybelsus) are used to treat conditions such as Type 2 diabetes and sleep apnea and are also often used for weight loss (whether FDA-approved or off-label)
Im just looking for options that feel true to me at this stage, knowing things can always change down the road
Since the affected area contains little or no pigment, it is difficult to detect in its early stages
A regular schedule to receive the injections can be customized to each individual